51
Participants
Start Date
December 15, 2021
Primary Completion Date
March 4, 2023
Study Completion Date
March 5, 2023
XTR003
"Enrolled subjects were required to fast for ≥ 6 hours before drug administration at rest;~1. Initial intravenous injection of 18F-FDG to each subject with a dose range of 2.0-3.0 mCi (74-111 MBq). Each patient will be imaged with PET for 10 minutes at 50-70 minutes after the injection.~2. In few minutes, a single intravenous bolus injection of XTR003 will follow and administer to each patient with a dose range of 6.0-8.0 mCi (222-296 MBq). Each patient will be immediately imaged with PET for 15 minutes."
TEDA International Cardiovascular Hospital, Tianjin
Sinotau Pharmaceutical Group
INDUSTRY